Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines.

Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN, Vaidya MM.

PLoS One. 2013;8(1):e53532. doi: 10.1371/journal.pone.0053532. Epub 2013 Jan 15.

2.

Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.

Alam H, Gangadaran P, Bhate AV, Chaukar DA, Sawant SS, Tiwari R, Bobade J, Kannan S, D'cruz AK, Kane S, Vaidya MM.

PLoS One. 2011;6(11):e27767. doi: 10.1371/journal.pone.0027767. Epub 2011 Nov 17.

3.

Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.

Mackinder MA, Evans CA, Chowdry J, Staton CA, Corfe BM.

Cancer Biomark. 2012;12(2):49-64. doi: 10.3233/CBM-120293.

PMID:
23396250
4.

Absence of keratins 8 and 18 in rodent epithelial cell lines associates with keratin gene mutation and DNA methylation: Cell line selective effects on cell invasion.

Kwan R, Looi KS, Omary MB.

Exp Cell Res. 2015 Jul 1;335(1):12-22. doi: 10.1016/j.yexcr.2015.04.003. Epub 2015 Apr 14.

5.

Loss of keratins 8 and 18 leads to alterations in α6β4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line.

Alam H, Kundu ST, Dalal SN, Vaidya MM.

J Cell Sci. 2011 Jun 15;124(Pt 12):2096-106. doi: 10.1242/jcs.073585. Epub 2011 May 24.

7.

Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation.

Fortier AM, Asselin E, Cadrin M.

J Biol Chem. 2013 Apr 19;288(16):11555-71. doi: 10.1074/jbc.M112.428920. Epub 2013 Feb 28.

8.

Differentially expressed genes associated with the metastatic phenotype in breast cancer.

Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ.

Breast Cancer Res Treat. 1999 May;55(2):127-36.

PMID:
10481940
9.

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.

Tate CR, Rhodes LV, Segar HC, Driver JL, Pounder FN, Burow ME, Collins-Burow BM.

Breast Cancer Res. 2012 May 21;14(3):R79.

10.

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.

Lehtinen L, Ketola K, Mäkelä R, Mpindi JP, Viitala M, Kallioniemi O, Iljin K.

Oncotarget. 2013 Jan;4(1):48-63.

11.
12.

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID:
17786294
14.

Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells.

Zeng GF, Cai SX, Wu GJ.

BMC Cancer. 2011 Mar 30;11:113. doi: 10.1186/1471-2407-11-113.

15.

Keratins regulate colonic epithelial cell differentiation through the Notch1 signalling pathway.

Lähdeniemi IAK, Misiorek JO, Antila CJM, Landor SK, Stenvall CA, Fortelius LE, Bergström LK, Sahlgren C, Toivola DM.

Cell Death Differ. 2017 Jun;24(6):984-996. doi: 10.1038/cdd.2017.28. Epub 2017 May 5.

16.

GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.

Yan W, Cao QJ, Arenas RB, Bentley B, Shao R.

J Biol Chem. 2010 Apr 30;285(18):14042-51. doi: 10.1074/jbc.M110.105262. Epub 2010 Feb 26.

17.

Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential.

Hendrix MJ, Seftor EA, Chu YW, Seftor RE, Nagle RB, McDaniel KM, Leong SP, Yohem KH, Leibovitz AM, Meyskens FL Jr, et al.

J Natl Cancer Inst. 1992 Feb 5;84(3):165-74.

PMID:
1371813
18.

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.

19.

The prognostic potential of keratin 18 in breast cancer associated with tumor dedifferentiation, and the loss of estrogen and progesterone receptors.

Ha SA, Lee YS, Kim HK, Yoo J, Kim S, Gong GH, Lee YK, Kim JW.

Cancer Biomark. 2011;10(5):219-31. doi: 10.3233/CBM-2012-0250.

PMID:
22699783
20.

Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).

Scribner KC, Behbod F, Porter WW.

Oncogene. 2013 May 23;32(21):2631-9. doi: 10.1038/onc.2012.286. Epub 2012 Jul 9.

Supplemental Content

Support Center